Property | Value |
?:abstract
|
-
The role of empirical and even directed antimicrobial management of patients hospitalized with SARS- CoV-2 infection is problematic; antibiotics are used frequently among these patients whether to treat confirmed or suspected co-infection or simply symptoms. In the rapidly changing clinical landscape of SARS- CoV-2 there is minimal guidance for selecting appropriate treatment versus non-antimicrobial treatment, and clinicians are pressed to make daily decisions under the stress of absence of data while watching patients deteriorate. We review current data and patterns of antimicrobial use and the potential approach for antimicrobial stewardship in the context of SARS- CoV-2.
|
is
?:annotates
of
|
|
?:creator
|
|
?:doi
|
|
?:doi
|
|
?:journal
|
|
?:license
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/313f1c29dccfab2523c3615225748e2dd77de8c6.json
|
?:pmcid
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
is
?:relation_isRelatedTo_publication
of
|
|
?:sha_id
|
|
?:source
|
|
?:title
|
-
Antimicrobial management of respiratory infections in SARS-CoV-2 patients: Clinical and ASP conundrums
|
?:type
|
|
?:year
|
|